Icon

MACROBID (nda020064)- (75MG;25MG)

NITROFURANTOIN; NITROFURANTOIN, MACROCRYSTALLINE ALMATICA
75MG;25MG
Yes No
2006-Jun-16 Expired
None None
None No
Macrobid is indicated only for the treatment of acute uncomplicated urinary tract infections (acute cystitis) caused by susceptible strains of Escherichia coli or Staphylococcus saprophyticus.
8 0 7
Total Other Developers 19
Drugs with Suitability No
75MG;25MG ** ** Down - 6
NDA Sales Available Total Generic Sales Available
Yes 6
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ****** ****** ****** ***************, *** *********** * *** ******* *** **** *, **********, *** ****** (**) *****-****, ****** ****** (***) ***
****** ****** ****** ****** ******* ******** ******** *** *********** *** ** ******* ***/***, ***********, *** ****** (**) *****-****, ****** ****** (***) ***
****** ***** ***** ************** ******* ******* *********** **. ***, ********* **., ****** ****., ****** ****, *****, ****** (***) ***
****** ******** ******** ********** ******* *********** **-**/*-***/*, ********** ********* **** ********* (****), *****, *********** ******, ***** (***) ***
****** ******** ******** ******* *************** ***. *********** *** ***** *****, *********, ******** (**) *****, ****** ****** (***) ***
****** ********* ****** ********* ****** ******* *********** ****-***, ** **. ***/*, ***/*, ***/*, ***/* & ***/*, **** ** **** ***, *****, ***** ********** ****, *********, ********* ******, ************, ********* ******, ***** (***) ***
****** ******* ****** ******* ****** ******* *********** ****-***, ******* *****, ****** **** ****, ***. ****** *******, ****** *****, *******, ******** ******* ******, ***** (***) ***
****** ***** ****** ***** **** ******* *********** **** **. *-*** ** *-*** & **, ***** *** & ***** **, ***** ********** ******, *****, *** ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.